project	sample	experiment	run	read_count_as_reported_by_sra	reads_downloaded	proportion_of_reads_reported_by_sra_downloaded	paired_end	sra_misreported_paired_end	mapped_read_count	auc	sharq_beta_tissue	sharq_beta_cell_type	biosample_submission_date	biosample_publication_date	biosample_update_date	avg_read_length	geo_accession	bigwig_file	title	characteristics
SRP029434	SRS475470	SRX342736	SRR961661	17725309	17725309	1	FALSE	FALSE	17246743	874548500	melanoma	esc	2013-09-03T10:00:00.850	2014-01-04T01:15:34.770	2014-03-07T15:20:02.465	51	GSM1220857	SRR961661.bw	shSOX10-1 RNA-seq	c("cell line: A375", "cell/tissue type: Human malignant melanoma cells", "transfected with: shSOX10")
SRP029434	SRS475471	SRX342735	SRR961660	24169071	24169071	1	FALSE	FALSE	23553152	1194280069	melanoma	esc	2013-09-03T09:59:58.807	2014-01-04T01:15:40.933	2014-03-07T15:20:02.432	51	GSM1220856	SRR961660.bw	PLKO RNA-seq	c("cell line: A375", "cell/tissue type: Human malignant melanoma cells", "transfected with: non-target shRNA control plasmid DNA")
SRP029434	SRS475472	SRX342737	SRR961662	22049358	22049358	1	FALSE	FALSE	21451162	1087630938	melanoma	esc	2013-09-03T09:51:33.307	2014-01-04T01:14:10.997	2014-03-07T15:20:02.158	51	GSM1220858	SRR961662.bw	shSOX10-2 RNA-seq	c("cell line: A375", "cell/tissue type: Human malignant melanoma cells", "transfected with: shSOX10")
SRP029434	SRS475473	SRX342738	SRR961663	38279003	38279003	1	FALSE	FALSE	37853782	1926734499	melanoma	esc	2013-09-03T09:51:50.773	2014-01-04T01:14:21.863	2014-03-07T15:20:02.396	51	GSM1220859	SRR961663.bw	Patient #5 pre RNA-seq	c("age: 53 yrs", "gender: female", "date of melanoma diagnosis: 2009-07-31", "type of primary melanoma: unknown", "site of primary melanoma: right axillary", "treatment (initiation date): TRAMETINIB (03/28/2011)", "date of biopsy i: 2011-03-28", "site of biopsy i: left thigh", "response at biopsy i: NA", "time to progression i: NA", "date of biopsy ii: 2011-10-24", "site of biopsy ii: left thigh", "response at biopsy ii: PD", "time to progression ii: 4 months", "cell/tissue type: tumor biopsy (FFPE) before treatment"
)
SRP029434	SRS475474	SRX342739	SRR961664	38591841	38591841	1	FALSE	FALSE	38175553	1942529854	melanoma	esc	2013-09-03T09:51:35.323	2014-01-04T01:14:01.633	2014-03-07T15:20:02.197	51	GSM1220860	SRR961664.bw	Patient #5 post RNA-seq	c("age: 53 yrs", "gender: female", "date of melanoma diagnosis: 2009-07-31", "type of primary melanoma: unknown", "site of primary melanoma: right axillary", "treatment (initiation date): TRAMETINIB (03/28/2011)", "date of biopsy i: 2011-03-28", "site of biopsy i: left thigh", "response at biopsy i: NA", "time to progression i: NA", "date of biopsy ii: 2011-10-24", "site of biopsy ii: left thigh", "response at biopsy ii: PD", "time to progression ii: 4 months", "cell/tissue type: tumor biopsy (FFPE) after treatment"
)
SRP029434	SRS475475	SRX342740	SRR961665	28929922	28929922	1	FALSE	FALSE	26228874	1325761049	melanoma	esc	2013-09-03T09:51:45.290	2014-01-04T01:14:14.017	2014-03-07T15:20:02.320	51	GSM1220861	SRR961665.bw	Patient #3 pre RNA-seq	c("age: 43 yrs", "gender: female", "date of melanoma diagnosis: 2010-09-08", "type of primary melanoma: SSM", "site of primary melanoma: right buttock", "treatment (initiation date): Dabrafenib (07/29/2011)", "date of biopsy i: 2010-09-08", "site of biopsy i: inguinal", "response at biopsy i: NA", "time to progression i: NA", "date of biopsy ii: 2012-05-24", "site of biopsy ii: peritoneal", "response at biopsy ii: PD", "time to progression ii: 10 months", "cell/tissue type: tumor biopsy (FFPE) before treatment"
)
SRP029434	SRS475476	SRX342741	SRR961666	32870665	32870665	1	FALSE	FALSE	31794800	1614701487	melanoma	esc	2013-09-03T09:51:37.423	2014-01-04T01:14:25.327	2014-03-07T15:20:02.237	51	GSM1220862	SRR961666.bw	Patient #3 post RNA-seq	c("age: 43 yrs", "gender: female", "date of melanoma diagnosis: 2010-09-08", "type of primary melanoma: SSM", "site of primary melanoma: right buttock", "treatment (initiation date): Dabrafenib (07/29/2011)", "date of biopsy i: 2010-09-08", "site of biopsy i: inguinal", "response at biopsy i: NA", "time to progression i: NA", "date of biopsy ii: 2012-05-24", "site of biopsy ii: peritoneal", "response at biopsy ii: PD", "time to progression ii: 10 months", "cell/tissue type: tumor biopsy (FFPE) after treatment"
)
SRP029434	SRS475477	SRX342742	SRR961667	25107343	25107343	1	FALSE	FALSE	23960387	1216643811	melanoma	esc	2013-09-03T09:51:47.113	2014-01-04T01:14:06.610	2014-03-07T15:20:02.358	51	GSM1220863	SRR961667.bw	Patient #2 pre RNA-seq	c("age: 66 yrs", "gender: male", "date of melanoma diagnosis: 2009-08-01", "type of primary melanoma: SSM", "site of primary melanoma: left thigh", "treatment (initiation date): Vemurafenib (03-13-2012)", "date of biopsy i: 2012-02-09", "site of biopsy i: right arm", "response at biopsy i: NA", "time to progression i: NA", "date of biopsy ii: 2012-06-25", "site of biopsy ii: thoracic skin", "response at biopsy ii: PD", "time to progression ii: < 7 months", "cell/tissue type: tumor biopsy (FFPE) before treatment"
)
SRP029434	SRS475478	SRX342743	SRR961668	39174126	39174126	1	FALSE	FALSE	36696762	1863215400	melanoma	esc	2013-09-03T09:51:39.357	2014-01-04T01:14:15.753	2014-03-07T15:20:02.278	51	GSM1220864	SRR961668.bw	Patient #2 post RNA-seq	c("age: 66 yrs", "gender: male", "date of melanoma diagnosis: 2009-08-01", "type of primary melanoma: SSM", "site of primary melanoma: left thigh", "treatment (initiation date): Vemurafenib (03-13-2012)", "date of biopsy i: 2012-02-09", "site of biopsy i: right arm", "response at biopsy i: NA", "time to progression i: NA", "date of biopsy ii: 2012-06-25", "site of biopsy ii: thoracic skin", "response at biopsy ii: PD", "time to progression ii: < 7 months", "cell/tissue type: tumor biopsy (FFPE) after treatment"
)